Picton Mahoney Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Picton Mahoney Asset Management's PFE Position: Q1 2026 in Review
Picton Mahoney Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 289,736 shares — an estimated $7.21M sold.
Picton Mahoney Asset Management first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $26.1M in Q1 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Picton Mahoney Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Picton Mahoney Asset Management sold 289,736 Pfizer shares in Q1 2026, an estimated $7.21M.
- Picton Mahoney Asset Management first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
- Picton Mahoney Asset Management's Pfizer position peaked at $26.1M in Q1 2014.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.